Massachusetts Financial Services CO Alkermes Plc. Transaction History

Massachusetts Financial Services CO

$282 Billion
Q1 2025

A detailed history of Massachusetts Financial Services CO transactions in Alkermes Plc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 42,430 shares of ALKS stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,430

Previous 43,398 2.23%

Holding current value

$1.33 Million

Previous $1.25 Million 12.26%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$28.08 - $36.0 $27,181 - $34,848	-968 Reduced 2.23%	42,430 $1.4 Million
Q4 2024 Feb 12, 2025	SELL	$25.7 - $31.46 $260,161 - $318,469	-10,123 Reduced 18.91%	43,398 $1.25 Million
Q3 2024 Nov 12, 2024	SELL	$23.01 - $28.55 $29,820 - $37,000	-1,296 Reduced 2.36%	53,521 $1.5 Million
Q2 2024 Aug 09, 2024	BUY	$23.21 - $27.24 $42,706 - $50,121	1,840 Added 3.47%	54,817 $1.32 Million
Q1 2024 May 14, 2024	SELL	$26.4 - $32.56 $3,115 - $3,842	-118 Reduced 0.22%	52,977 $1.43 Million
Q4 2023 Feb 08, 2024	SELL	$23.37 - $28.68 $39,168 - $48,067	-1,676 Reduced 3.06%	53,095 $1.47 Million
Q3 2023 Nov 08, 2023	SELL	$27.17 - $31.97 $57,002 - $67,073	-2,098 Reduced 3.69%	54,771 $1.53 Million
Q2 2023 Aug 09, 2023	BUY	$28.34 - $33.63 $933,264 - $1.11 Million	32,931 Added 137.57%	56,869 $1.78 Million
Q1 2023 May 10, 2023	SELL	$25.31 - $29.02 $17,109 - $19,617	-676 Reduced 2.75%	23,938 $674,000
Q4 2022 Feb 13, 2023	BUY	$21.94 - $26.24 $11,452 - $13,697	522 Added 2.17%	24,614 $643,000
Q3 2022 Nov 09, 2022	BUY	$22.0 - $31.87 $530,024 - $767,812	24,092 New	24,092 $538,000
Q1 2022 May 11, 2022	SELL	$23.07 - $27.99 $1.93 Million - $2.35 Million	-83,794 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$21.47 - $32.08 $36,456 - $54,471	-1,698 Reduced 1.99%	83,794 $1.95 Million
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $351,835 - $483,717	15,055 Added 21.37%	85,492 $2.64 Million
Q2 2021 Aug 13, 2021	BUY	$18.78 - $25.15 $11,343 - $15,190	604 Added 0.86%	70,437 $1.73 Million
Q1 2021 May 13, 2021	BUY	$18.21 - $23.2 $1.27 Million - $1.62 Million	69,833 New	69,833 $1.3 Million

Others Institutions Holding ALKS

# of Institutions

410

Shares Held

177M

Call Options Held

229K

Put Options Held

436K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.14B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Alkermes Plc. Transaction History